It has been generally demonstrated that the valine-to-glutamic acid substitution at position 600 (V600E) in the v-Raf murine sarcoma viral oncogene homolog B1 (BRAF) gene is an effective diagnostic/prognostic marker mainly for papillary thyroid carcinoma (PTC). The detection of this mutation typically has been achieved using DNA-based techniques. The recently introduced monoclonal V600E antibody (clone VE1) is likely to be an alternative strategy for detecting this mutation in thyroid lesions. The authors investigated molecular and immunocytohistochemical BRAF analyses in a prospective series of samples from patients with PTC.
Rossi, E., Martini, M., Capodimonti, S., Cenci, T., Straccia, P., Angrisani, B., Ricci, C., Lanza, P., Lombardi, C. P., Pontecorvi, A., Larocca, L. M., Fadda, G., Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience, <<CANCER CYTOPATHOLOGY>>, 2014; (N/A): N/A-N/A. [doi:10.1002/cncy.21416] [http://hdl.handle.net/10807/55521]
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience
Rossi, Esther;Martini, Maurizio;Capodimonti, Sara;Cenci, Tonia;Straccia, Patrizia;Angrisani, Basilio;Lanza, Paola;Lombardi, Celestino Pio;Pontecorvi, Alfredo;Larocca, Luigi Maria;Fadda, Guido
2014
Abstract
It has been generally demonstrated that the valine-to-glutamic acid substitution at position 600 (V600E) in the v-Raf murine sarcoma viral oncogene homolog B1 (BRAF) gene is an effective diagnostic/prognostic marker mainly for papillary thyroid carcinoma (PTC). The detection of this mutation typically has been achieved using DNA-based techniques. The recently introduced monoclonal V600E antibody (clone VE1) is likely to be an alternative strategy for detecting this mutation in thyroid lesions. The authors investigated molecular and immunocytohistochemical BRAF analyses in a prospective series of samples from patients with PTC.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
